NeuroThera (R) Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera (R) Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset INTERNATIONAL JOURNAL OF STROKE Zivin, J. A., Sehra, R., Shoshoo, A., Albers, G. W., Bornstein, N. M., Dahlof, B., Kasner, S. E., Howard, G., Shuaib, A., Streeter, J., Richieri, S. P., Hacke, W. 2014; 9 (7): 950-955

View details for DOI 10.1111/j.1747-4949.2012.00896.x

View details for Web of Science ID 000342581900029